Scale-Out and -Up Strategies

CELL AND GENE THERAPY INSIGHTS

Scale-Out and -Up Strategies

October 2017
Scale-Out and -Up Strategies
Download PDF

Expert Insight

Obstacles for rAAV Clinical Trials: a question of vector supply and demand or know-how

Obstacles for rAAV Clinical Trials: a question of vector supply and demand or know-how

16 November 2017
Read
Scale-up of lentiviral vectors for gene therapy: advances and challenges

Scale-up of lentiviral vectors for gene therapy: advances and challenges

Alexandra McCarron, Martin Donnelley, David Parsons
16 November 2017
Read
Scale-up of platelet production from human pluripotent stem cells for developing targeted therapies: advances & challenges

Scale-up of platelet production from human pluripotent stem cells for developing targeted therapies: advances & challenges

Jonathan N Thon, Sven M Karlsson
16 November 2017
Read

Interview

Importance of Innovation and Design in the Scalability of Cell & Gene Therapies

Importance of Innovation and Design in the Scalability of Cell & Gene Therapies

Stephen Ward, Julie Kerby, Damian Marshall
27 November 2017
Read
Approaches and challenges for the manufacture and scale-out of autologous cell therapies

Approaches and challenges for the manufacture and scale-out of autologous cell therapies

Richard Harrison
16 November 2017
Read

Podcast

Importance of Innovation and Design in the Scalability of Cell & Gene Therapies

Importance of Innovation and Design in the Scalability of Cell & Gene Therapies

Stephen Ward, Julie Kerby, Damian Marshall
3 December 2017
Listen